Next Article in Journal
Deciphering Rhizosphere Microbiome Assembly of Castanea henryi in Plantation and Natural Forest
Next Article in Special Issue
Translational Fusion to Hmp Improves Heterologous Protein Expression
Previous Article in Journal
Human Colonic Microbiota and Short-Term Postoperative Outcomes in Colorectal Cancer Patients: A Pilot Study
Previous Article in Special Issue
The Discovery of Vitreoscilla Hemoglobin and Early Studies on Its Biochemical Functions, the Control of Its Expression, and Its Use in Practical Applications
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Vitreoscilla Haemoglobin: A Tool to Reduce Overflow Metabolism

by
Hilal Taymaz-Nikerel
1 and
Alvaro R. Lara
2,*
1
Department of Genetics and Bioengineering, Istanbul Bilgi University, Istanbul 34060, Turkey
2
Departamento de Procesos y Tecnología, Universidad Autónoma Metropolitana, Mexico City 05348, Mexico
*
Author to whom correspondence should be addressed.
Microorganisms 2022, 10(1), 43; https://doi.org/10.3390/microorganisms10010043
Submission received: 18 November 2021 / Revised: 18 December 2021 / Accepted: 20 December 2021 / Published: 26 December 2021
(This article belongs to the Special Issue Microbial Hemoglobins)

Abstract

:
Overflow metabolism is a phenomenon extended in nature, ranging from microbial to cancer cells. Accumulation of overflow metabolites pose a challenge for large-scale bioprocesses. Yet, the causes of overflow metabolism are not fully clarified. In this work, the underlying mechanisms, reasons and consequences of overflow metabolism in different organisms have been summarized. The reported effect of aerobic expression of Vitreoscilla haemoglobin (VHb) in different organisms are revised. The use of VHb to reduce overflow metabolism is proposed and studied through flux balance analysis in E. coli at a fixed maximum substrate and oxygen uptake rates. Simulations showed that the presence of VHb increases the growth rate, while decreasing acetate production, in line with the experimental measurements. Therefore, aerobic VHb expression is considered a potential tool to reduce overflow metabolism in cells.

1. Overflow Metabolism and Bioprocessing

Fast growing cells often display incomplete oxidation of the carbon source, even if oxygen is present in non-limiting amounts. As a result, partially oxidized molecules, rather than CO2, are excreted to the environment. This phenomenon was already observed for yeasts by Louis Pasteur in 1861 [1] and later on in muscle cells [2], carcinoma cells [3] and normal tissues after viral infection [4]. Traditionally referred to as the “Pasteur”, “Warburg” and “Crabtree” effect, such a metabolic state is collectively known as overflow metabolism [5].
The biotechnological production of molecules requires the transformation of a substrate (most commonly glucose) into the desired molecule. Because these are autocatalytic processes, the amount of product that can be synthesized depends on the amount of cells in the culture. Therefore, a standard procedure to maximize the amount of synthesized product is to attain an elevated amount of cells in the culture. These so-called high cell-density cultures require elevated amounts of carbon source that lead to overflow metabolism.
Examples of overflow metabolites excreted by organisms of biotechnological relevance are shown in Table 1. The accumulation of such by-products lowers the pH of the broth, affecting the cellular physiology. The continuous addition of alkali to control pH can result in the accumulation of ions and osmolality increase that can negatively affect the cells. Moreover, the formation of overflow metabolites can be seen as a waste of carbon that otherwise could have been incorporated to biomass and/or product. For instance, the amount of acetate produced as overflow metabolite can be as high as 15% (w/w) of the carbon source (glucose) consumed [6].
Diverse strategies have been applied to reduce overflow metabolism in different organisms, including genetic interventions [7] and the slow addition of the carbon source (fed-batch cultures) [8]. Nevertheless, all the proposed solutions also imply disadvantages. Furthermore, despite the relevance of overflow metabolism from a physiological and biotechnological standpoint, its causes are not clearly understood. Some possible explanations are briefly presented below.

1.1. Causes of Overflow Metabolism

1.1.1. Metabolic Imbalance

A relatively straightforward explanation of overflow metabolism considers that a metabolic imbalance between catabolism and anabolism occurs at high glucose uptake rates (qS) [17]. At low qS, the substrate can be fully oxidized via the tricarboxylic acid cycle (TCA) and NADH regenerated by the electron transport chain (Figure 1). Increasing qS is accompanied by an increased oxygen consumption rate (qO2). After a certain threshold value of glucose uptake (qs,crit), overflow metabolites start to accumulate. This coincides with a maximum rate of oxygen consumption (qO2, max). Above this respiratory capacity, qS can continue to increase, with the concomitant synthesis of overflow metabolites (for example, for E. coli cultures, see [18]). NADH regeneration rate could not be reached by the electron transport chain only, and therefore, fermentative pathways are activated. TCA activity can also be lowered [19]. Enzyme capacity constraints combined with flux balance analysis using a genome-scale model predicted the lactate shift in CHO cells coincident with a plateau in the oxidative phosphorylation flux and specific CO2 formation rate (qCO2) patterns in relation to qS [20].
Maintaining the cells growing at qS < qS,crit in fed-batch cultures avoids overflow metabolism and allows attaining high cell-densities. This principle has been successfully applied to a variety of microbial and animal cells [21]. Decreasing qS by genetic manipulation has also been a successful strategy to reduce overflow metabolism in E. coli [22,23,24,25] and CHO cells [26]. Although overflow metabolism can be completely suppressed by this approach, growth rate (μ) is also affected. The activity of the tricarboxylic acid cycle (TCA) in E. coli was increased to better cope with the high glycolytic flux at elevated qS, which decreased acetate formation [27]. Another approach to overcome overflow metabolism considering a metabolic imbalance was to increase the NAD+ regeneration rate. For instance, Vemuri and co-workers expressed a water-forming heterologous dehydrogenase in E. coli and S. cerevisiae [19,28]. Despite the strong reduction of overflow metabolism, a decrease on biomass yield was observed, which is probably linked to the waste of reductive power to form water instead of contributing to a proton gradient. The metabolic causes of overflow metabolism in mammalian cells can be more complex. For instance, Bulté and co-workers [29] proposed that pyruvate transport to the mitochondria could be a limiting factor for its complete oxidation, leading to lactate synthesis in the cytoplasm. The researchers enhanced pyruvate transport by overexpressing a mitochondrial pyruvate carrier in CHO cells, which resulted in up to 50% decrease of aerobic lactate production.
The approach of metabolic imbalance can partially explain the causes of overflow metabolism and inspire some genetic interventions to reduce it. However, other hypotheses have been proposed from different perspectives, as explained below.

1.1.2. Proteome Allocation

Peebo and co-workers [30] analysed the proteome of E. coli growing at different μ. They found that as μ increased, the abundance of proteins related to carbohydrate transport and metabolism lowered, while those related to translation increased. In order to quantitatively describe the effects on the proteome, the authors defined the investment of translational capacity as the “protein expression cost” (defined as the product of the protein concentration multiplied by its length in amino acids). The expression cost of the ATP synthase and NADH dehydrogenase I relative to the total proteome increased proportionally to μ and reached a plateau coincident with the shift to overflow metabolism. Although the authors did not clearly link these results with the control of overflow metabolism, they suggested that E. coli shifts to a more economic protein usage. Due to the high demand of protein resource for the respiratory chain (ATP synthase requiring up to 2.5% of the total translational capacity), different mechanisms for energy production are preferred. This hypothesis was analysed in detail by Basan and co-workers using E. coli as a model organism [31]. The authors described that, although respiration is more efficient to generate energy than fermentation, the proteome cost of the former is much higher than for the latter. For glycolytic carbon sources, the authors calculated that the proteome efficiency of energy biogenesis is approx. 750 mM ATP/A600nm/h for fermentation, while for respiration it was approx. 390 mM ATP/A600nm/h. Therefore, the authors proposed that overflow metabolism is a programmed global response of the cells to cope with the proteome demands for energy generation. Further modelling and flux balance analysis have been applied to predict overflow metabolism in E. coli [32]. Chen and Nielsen [33] also modelled the energy metabolism of E. coli and S. cerevisiae coupled to proteomic analysis to successfully predict the start of overflow metabolism in relation to μ, qS, or ATP rate. Interestingly, they found that the differences between energy yields of respiration and fermentation were much larger for E. coli than for S. cerevisiae. Proteome allocation coupled with dynamic flux balance analysis and adjustable maintenance energy level allowed good prediction of growth overflow metabolism and recombinant protein production of engineered E. coli strains [34].
The hypothesis of proteome allocation as the origin of overflow metabolism has also been evaluated for Lactococcus lactis [35] and Clostridium ljungdahlii [36]. Proteome reduction to develop minimal cells has been reported for E. coli [37]. Proteome-reduced E. coli strains have a superior performance for plasmid DNA vaccines production in batch and fed-batch mode [38]. However, overflow metabolism in proteome-reduced cells has not yet been thoroughly tested.

1.1.3. Molecular Crowding

It has been suggested that cells have evolved to maintain the enzyme-protein levels at the minimum level compatible with function. The volume occupied by proteins in the cell is 20–30% of the cell volume (determined for bacterial, yeast and mammalian cells). This large proportion may limit the diffusion and solubility of molecules in the cell due to the viscosity of the remaining unbound water [39]. Therefore, it is possible that not only the efficiency to produce ATP, but also the amount of proteins (and the volume) needed for a given pathway may be key for the cell to choose a particular energy-generation mechanism [40]. This hypothesis has been tested using modelling and experimental measurements. A flux balance model of the metabolism of E. coli including the constraint for the concentration of enzymes, named “FBA with Molecular Crowding” (FBAwMC) was introduced by Beg and co-workers [41]. This model could predict the sequence of utilization of carbon sources in mixtures, as well as μ. Although overflow metabolism was also predicted, the model estimated a lesser excretion of acetate than the experimentally determined. FBAwMC was refined and combined with enzyme activity measurements to analyze metabolic shifts from low to high μ in E. coli [42]. Vazquez et al. [43] applied FbwMC to simulate the overflow metabolism of murine LS and hybridoma cells. The shift to lactate production and the threshold qS values were estimated with good accuracy. According to their calculations, the mitochondria contribute 5 times more to molecular crowding than glycolytic enzymes and 50 times more than lactate dehydrogenase. Van Hoek and co-workers used FBAwMC to study the metabolism of L. lactis and S. cerevisiae yielding interesting results [44]. In agreement with previous independent reports, the authors concluded that the shift to lactate production is determined by the existence of a limited cytoplasmic solvent capacity for allocating the components of the ATP generation pathways.
Important elements of the energy production cellular machinery are located in the membranes. Therefore, molecular crowding of the membrane can be a limiting factor to shift from purely aerobic to aerobic-fermentative energy production. For example, crowding of the cytochromes in the membrane of E. coli was introduced as an additional constraint in FBA [45]. The well-known differential use of cytochromes depending on qS and oxygen availability was well simulated. However, the qS,crit obtained did not agree with the experimental data. This could be probably due to the fact that other important molecules, such as ATPase were not considered. In a more comprehensive study, Szenk et al. [46] integrated the μ-dependent surface-to-volume ratio, as well as the physical size and of the proteins involved in respiration and fermentation, to evaluate whether pure respiration could be limited by membrane crowding at fast μ. According to their calculation, the surface efficiency (given in ATP/s/nm2) for aerobic respiration is three, while it reaches a value of 15 for acetate fermentation. Furthermore, they found that the percentage of the membrane occupied by the electron transport chain component increases with the growth rate, and plateau at a value of ca. 8%, coincident with the onset of overflow metabolism. Moreover, the authors linked the surface efficiency with the phosphate/oxygen (P/O, depending on the molecules of ATP produced per NADH equivalent) ratio. P/O ratio decreases when the surface efficiency increases (fermentation), and the growth rates at which overflow metabolism triggers are higher at lower P/O ratios.

2. Vitreoscilla Haemoglobin as a Tool to Reduce Overflow Metabolism

2.1. Aerobic Expression of Vitreoscilla Hemoglobin

The haemoglobin of the aerobic bacteria Vitreoscilla stercoraria (VHb) is a single domain haemoglobin that exists as a dimeric protein of two identical subunits with a mass of 15.7 Da each [47]. Initially identified as a cytochrome, evidence was provided showing that VHb can pump Na+ transmembranally, instead of protons [48]. VHb displays a remarkably high capacity for oxygen delivery to terminal oxidases (high dissociation rate koff = 78 mM−1 s−1) [47]. In consequence, VHb has been used as a strategy to improve cellular performance, particularly under oxygen-limited environments, enhancing the qO2 and μ and biomass formation (for reviews see [47,49,50,51,52]). The impact of VHb expression is ample and some features depend on the host. The effect of VHb has been mostly characterized in E. coli cells. In E. coli, VHb expression restored the oxygen consumption in a strain lacking both cytochromes (Cyo and Cyd), reaching 70% of the respiration rate of the wild type strain [53], and is physiologically active in the oxygen-carrying form during aerobic respiration [54]. The H+/O ratio, the transmembrane ΔpH, and the ATP content of VHb-expressing E. coli cells were 1.5, 1.6 and 2 times greater, respectively, than the corresponding values in non-expressing cells [55]. VHb-expressing E. coli cells displayed higher oxidative activity than non-expressing cells, as indicated by the Redox Sensor Green fluorescence [56].
Cellular localization of VHb has also been investigated, due to its relationship with the respiration proteins. Khosla and Bailey [57], using fractionation and proteinase K accessibility techniques, determined that nearly 40% of VHb is in the periplasmic space in E. coli. In contrast, Ramandeep and co-workers [58], using immunogold labelling reported that more than 90% of the VHb was located in the periplasm of E. coli, and that 57% of the VHb was localized within 0.1 μm of the inner membrane. Using immunofluorescence microscopy, Juarez and co-workers found that VHb is distributed in the cytoplasm and the membranes of organelles in CHO cells [59]. Because periplasmic localization of VHb would enhance the effect of VHb on the electron transport chain, VHb was fused to OmpA and expressed in E. coli [58]. Approximately 50% of the OmpA-VHb was located in the periplasmic space. However, no improvement of the growth characteristics or oxygen consumption, compared to the unfused VHb expression, were observed. The authors speculated that cytoplasmic location of VHb may provide an oxygen buffer to facilitate oxygen delivery to the terminal oxidase that are oriented toward the cytoplasm. The authors also mentioned that non-functional apoprotein could have accumulated in the periplasmic space, explaining the lack of effects observed. More recently, the twin-arginine translocase pathway was used to export active VHb into the periplasmic space of Halomonas bluephagenesis. This improved cell formation and poly (3-hydroxybutyrate) production under oxygen limitation [60]. Moreover, the authors shown that the intracellular and periplasmic VHb expression increased the amount of proteins related to aerobic respiration in H. bluephagenesis, particularly cytochromes and beta subunit of the ATP synthase. Therefore, the presence of VHb affects respiratory efficiency not only by increasing oxygen transport, but also by increasing a higher amount of enzymes of the respiratory chain. This contributes to a better understanding of the enhanced respiratory capacity of cells expressing VHb.
In comparison with the relatively abundant information on the use of VHb for improving bioprocesses under oxygen limitation, the application of VHb for aerobic cultures is scarce. Table 2 shows examples of VHb expression under fully aerobic conditions and the reported effects. Particular physiological responses depend on the host organism and even on the strain used. However, a common factor of the different reports is that higher oxygen uptake and ATP generation can benefit the culture performance. A key aspect to be addressed is the impact of VHb on the overflow metabolism of cells. There are few but relevant reports showing that aerobic VHb expression, in fact, reduces overflow metabolism (for instance in E. coli and CHO cells, Table 2). Therefore, VHb expression could be an efficient and simple strategy to overcome overflow metabolism. Potential metabolic reasons for this are discussed below.

2.2. Metabolic Consequences of Aerobic Expression of Vitreoscilla Haemoglobin

As explained before, overflow metabolism has been associated with fast growth, since under fast growth energy is generated via fermentation instead of respiration. In addition to bacteria and fungi many other organisms—mammalian cells, plants—use respiration at low glucose uptake rates and aerobic fermentation at high glucose uptake rates [73]. It was shown that NAD+/NADH ratio is key to the metabolic differences between the metabolic switches: redox balance is one of the factors leading to overflow metabolism [19,44,74]. As a consequence, cofactor redox engineering strategies have been developed for industrial applications [75].
Using a network-based approach a recent study suggested that there is an upper limit to the Gibbs energy release rate of E. coli and S. cerevisiae [76]. Due to the different reactions in fermentative pathways and oxidative phosphorylation, thermodynamic driving force in terms of Gibbs energy change is different between those. The authors suggested that this limit in thermodynamics of metabolism might explain the overflow metabolism, since they observed that flux distributions were shifted from respiratory pathways to fermentative pathways with increasing substrate uptake rates.
Through a kinetic model of E. coli it was suggested that overflow metabolism should be considered a reversible process and be universal including ethanol consumption by S. cerevisiae and lactate by mammalian cells [77]. Mori et al. [78] combined genome-scale modelling with experimental data to characterize yield-cost trade-off in E. coli and found that the efficiency of ATP synthesis is the key driver.
Fifteen models of overflow metabolism have been reviewed recently [79]. In addition to the above mentioned constraints of free energy dissipation [76], total proteome [31,79], membrane occupancy [45,46]; the constraints such as electron transfer capacity, oxygen uptake rate, and macromolecular density were observed to be used. Overflow metabolism was also interpreted from the perspective of the regulation of oxidative stress [80] since growth increases as a response to oxidative stress. The trade-off between glucose uptake rate and growth yield was related to the changes in P/O ratio and the flux allocation between glycolysis and pentose phosphate pathway [81]. It has been demonstrated that the presence of VHb in E. coli enhanced by 5-fold the content of the cytochrome bo and by 1.5 –fold the content of the cytochrome bd in cells of E. coli [82]. Cytochrome O works as a proton pump, mobilizing 2 protons per electron (H+/e = 2). In contrast, an H+/e ratio of 1 is obtained by cytochrome bd [83]. Therefore, it is reasonable to expect that the presence of VHb alters the P/O ratio.
Here, to investigate the effect of P/O ratio on the overflow metabolism, flux balance analysis (FBA) was carried out using E. coli genome scale model [84] in COBRA toolbox [85]. Following the approach in Taymaz-Nikerel et al. [86], the P/O ratio, was varied by modifying the stoichiometry of the reactions catalysed by NADH dehydrogenase (NADH10, NADH16pp, NADH17pp, NADH18pp), FADH dehydrogenase (FDH4pp) and cytochrome oxidases (CYTBD2pp, CYTBDpp, CYTBO3_4pp). Table 3 summarizes the implemented stoichiometric coefficients.
Theoretically P/O ratio in E. coli varies between 0.67 and 2.67 [87]. For constraints of FBA, maximum glucose uptake rate of E. coli, namely qS = −11 mmol g−1h−1 [88] and qO2 = −8 mmol g−1h−1 values were implemented for wild type (Figure 2). For the second case addition to maximum glucose uptake rate of qS = −11 mmol g−1h−1, maximum O2 uptake rate of qO2 = −15 mmol g−1h−1 [89] were used (Figure 3) for the wild type. In the presence of VHb cases, addition to the same qS values, 25% higher O2 uptake rates were set due to the experimental measurements [66]. The values for qO2 was selected to cover from relatively low to maximum capacity of the cell. To see the effect of P/O ratio on overflow metabolism, runs for varying P/O were carried out. At low P/O ratio values, acetate production rate was higher, in agreement with the finding that decreased P/O ratios yielded in higher rate of acetate production [81]. In all the cases studied/simulated bd-type cytochrome oxidases replace bo-type for P/O > 1. This might be related with the observation that the fraction of ATP produced by the electron transport chain is higher at high P/O ratios [46]. When qO2 is at its maximum value (Figure 3) in the presence of VHb, qCO2 decreases after P/O ratio of around 2.
Figure 2 and Figure 3 clearly show the effect of P/O ratio on the overflow metabolism as acetate production decreases by increasing P/O ratio, consistent with the work of Szenk et al. 2017 [46]. At a fixed qO2, growth rate is maximized at stable µ below P/O ratio of 1. For P/O ratio > 1 maximum growth rate increases with increasing P/O ratio. bo-type and bd-type cytochrome oxidases replace each other for P/O ratio below 1 and above 1.
In the presence of VHb, it was observed that qO2 was around 20% higher [66] compared to that in cells without VHb. Acetate production is lower when VHb is present, consistent with previous experimental findings [65] and even totally diminishes at higher qO2 (Figure 3). This implies possibilities for modification of aerobic respiratory chains of organisms to change P/O ratio (different ATP yields) and thus lower the impacts of overflow metabolism, although the complex responses of the organism(s) should not be avoided. On the other hand, it has already been mentioned that the periplasmic proteome of cells can change in response to VHb expression. This may be an adaptation to a presumably crowded section of the cell in order to increase energy production.
These simulations may help to understand how VHb could contribute to reduce production of overflow metabolites. Considerable investigations are still needed to better understand the physiological changes caused by aerobic VHb expression. Nevertheless, the current available information point to VHb technology as a strong ally to improve aerobic bioprocesses.

Author Contributions

Conceptualization, A.R.L. and H.T.-N.; software, H.T.-N.; validation, H.T.-N.; investigation, A.R.L. and H.T.-N.; writing—original draft preparation, A.R.L. and H.T.-N.; writing—review and editing, A.R.L. and H.T.-N. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. PORTER, J.R. Louis PASTEUR; achievements and disappointments, 1861. Bacteriol. Rev. 1961, 25, 389–403. [Google Scholar] [CrossRef] [PubMed]
  2. Fletcher, W.M. Lactic acid in amphibian muscle. J. Physiol. 1907, 35, 247–309. [Google Scholar] [CrossRef]
  3. Warburg, O.; Minami, S. Versuche an überlebendem carcinom-gewebe. Klin. Wochenschr. 1923, 2, 776–777. [Google Scholar] [CrossRef]
  4. Crabtree, H.G. The carbohydrate metabolism of certain pathological overgrowths. Biochem. J. 1928, 22, 1289–1298. [Google Scholar] [CrossRef] [Green Version]
  5. Vazquez, A. Overflow Metabolism: From Yeast to Marathon Runners, 1st ed.; Academic Press: London, UK, 2018. [Google Scholar]
  6. Holms, W.H. The central metabolic pathways of Escherichia coli: Relationship between flux and control at a branch point, efficiency of conversion to biomass, and excretion of acetate. Curr. Top Cell. Regul. 1986, 28, 69–105. [Google Scholar] [CrossRef]
  7. De Mey, M.; De Maeseneire, S.; Soetaert, W.; Vandamme, E. Minimizing acetate formation in E. coli fermentations. J. Ind. Microbiol. Biotechnol. 2007, 34, 689–700. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Eiteman, M.A.; Altman, E. Overcoming acetate in Escherichia coli recombinant protein fermentations. Trends Biotechnol. 2006, 24, 530–536. [Google Scholar] [CrossRef] [PubMed]
  9. Ma, W.; Liu, Y.; Lv, X.; Li, J.; Du, G.; Liu, L. Combinatorial pathway enzyme engineering and host engineering overcomes pyruvate overflow and enhances overproduction of N-acetylglucosamine in Bacillus subtilis. Microb. Cell Fact. 2019, 18, 1. [Google Scholar] [CrossRef] [Green Version]
  10. Luo, J.; Vijayasankaran, N.; Autsen, J.; Santuray, R.; Hudson, T.; Amanullah, A.; Li, F. Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process. Biotechnol. Bioeng. 2012, 109, 146–156. [Google Scholar] [CrossRef] [PubMed]
  11. Thompson, R.A.; Trinh, C.T. Overflow metabolism and growth cessation in Clostridium thermocellum DSM1313 during high cellulose loading fermentations. Biotechnol. Bioeng. 2017, 114, 2592–2604. [Google Scholar] [CrossRef]
  12. Wittmann, C.; Kiefer, P.; Zelder, O. Metabolic fluxes in Corynebacterium glutamicum during lysine production with sucrose as carbon source. Appl. Environ. Microbiol. 2004, 70, 7277–7287. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Paczia, N.; Nilgen, A.; Lehmann, T.; Gätgens, J.; Wiechert, W.; Noack, S. Extensive exometabolome analysis reveals extended overflow metabolism in various microorganisms. Microb. Cell Fact. 2012, 11, 122. [Google Scholar] [CrossRef] [Green Version]
  14. Nanda, P.; Patra, P.; Das, M.; Ghosh, A. Reconstruction and analysis of genome-scale metabolic model of weak Crabtree positive yeast Lachancea kluyveri. Sci. Rep. 2020, 10, 16314. [Google Scholar] [CrossRef] [PubMed]
  15. Schmitz, K.; Peter, V.; Meinert, S.; Kornfeld, G.; Hardiman, T.; Wiechert, W.; Noack, S. Simultaneous utilization of glucose and gluconate in Penicillium chrysogenum during overflow metabolism. Biotechnol. Bioeng. 2013, 110, 3235–3243. [Google Scholar] [CrossRef]
  16. Nocon, J.; Steiger, M.G.; Pfeffer, M.; Sohn, S.B.; Kim, T.Y.; Maurer, M.; Rußmayer, H.; Pflügl, S.; Ask, M.; Haberhauer-Troyer, C.; et al. Model based engineering of Pichia pastoris central metabolism enhances recombinant protein production. Metab. Eng. 2014, 24, 129–138. [Google Scholar] [CrossRef] [PubMed]
  17. Majewski, R.A.; Domach, M.M. Simple constrained-optimization view of acetate overflow in E. coli. Biotechnol. Bioeng. 1990, 35, 732–738. [Google Scholar] [CrossRef] [PubMed]
  18. Kayser, A.; Weber, J.; Hecht, V.; Rinas, U. Metabolic flux analysis of Escherichia coli in glucose-limited continuous culture. I. Growth-rate-dependent metabolic efficiency at steady state. Microbiology 2005, 151, 693–706. [Google Scholar] [CrossRef] [Green Version]
  19. Vemuri, G.N.; Altman, E.; Sangurdekar, D.P.; Khodursky, A.B.; Eiteman, M.A. Overflow metabolism in Escherichia coli during steady-state growth: Transcriptional regulation and effect of the redox ratio. Appl. Environ. Microbiol. 2006, 72, 3653–3661. [Google Scholar] [CrossRef] [Green Version]
  20. Yeo, H.C.; Hong, J.; Lakshmanan, M.; Lee, D.Y. Enzyme capacity-based genome scale modelling of CHO cells. Metab. Eng. 2020, 60, 138–147. [Google Scholar] [CrossRef]
  21. Shojaosadati, S.A.; Kolaei, S.M.V.; Babaeipour, V.; Farnoud, A.M. Recent advances in high cell density cultivation for production of recombinant protein. Iran. J. Biotechnol. 2008, 6, 63–84. [Google Scholar]
  22. De Anda, R.; Lara, A.R.; Hernández, V.; Hernández-Montalvo, V.; Gosset, G.; Bolívar, F.; Ramírez, O.T. Replacement of the glucose phosphotransferase transport system by galactose permease reduces acetate accumulation and improves process performance of Escherichia coli for recombinant protein production without impairment of growth rate. Metab. Eng. 2006, 8, 281–290. [Google Scholar] [CrossRef]
  23. Fuentes, L.G.; Lara, A.R.; Martínez, L.M.; Ramírez, O.T.; Martínez, A.; Bolívar, F.; Gosset, G. Modification of glucose import capacity in Escherichia coli: Physiologic consequences and utility for improving DNA vaccine production. Microb. Cell Fact. 2013, 12, 42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Negrete, A.; Majdalani, N.; Phue, J.N.; Shiloach, J. Reducing acetate excretion from E. coli K-12 by over-expressing the small RNA SgrS. New Biotechnol. 2013, 30, 269–273. [Google Scholar] [CrossRef] [Green Version]
  25. Bäcklund, E.; Markland, K.; Larsson, G. Cell engineering of Escherichia coli allows high cell density accumulation without fed-batch process control. Bioprocess Biosyst. Eng. 2008, 31, 11–20. [Google Scholar] [CrossRef] [PubMed]
  26. Wlaschin, K.F.; Hu, W.S. Engineering cell metabolism for high-density cell culture via manipulation of sugar transport. J. Biotechnol. 2007, 131, 168–176. [Google Scholar] [CrossRef] [PubMed]
  27. Veit, A.; Polen, T.; Wendisch, V.F. Global gene expression analysis of glucose overflow metabolism in Escherichia coli and reduction of aerobic acetate formation. Appl. Microbiol. Biotechnol. 2007, 74, 406–421. [Google Scholar] [CrossRef]
  28. Vemuri, G.N.; Eiteman, M.A.; McEwen, J.E.; Olsson, L.; Nielsen, J. Increasing NADH oxidation reduces overflow metabolism in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 2007, 104, 2402–2407. [Google Scholar] [CrossRef] [Green Version]
  29. Bulté, D.B.; Palomares, L.A.; Parra, C.G.; Martínez, J.A.; Contreras, M.A.; Noriega, L.G.; Ramírez, O.T. Overexpression of the mitochondrial pyruvate carrier reduces lactate production and increases recombinant protein productivity in CHO cells. Biotechnol. Bioeng. 2020, 117, 2633–2647. [Google Scholar] [CrossRef]
  30. Peebo, K.; Valgepea, K.; Maser, A.; Nahku, R.; Adamberg, K.; Vilu, R. Proteome reallocation in Escherichia coli with increasing specific growth rate. Mol. Biosyst. 2015, 11, 1184–1193. [Google Scholar] [CrossRef]
  31. Basan, M.; Hui, S.; Okano, H.; Zhang, Z.; Shen, Y.; Williamson, J.R.; Hwa, T. Overflow metabolism in Escherichia coli results from efficient proteome allocation. Nature 2015, 528, 99–104. [Google Scholar] [CrossRef] [Green Version]
  32. Zeng, H.; Yang, A. Modelling overflow metabolism in Escherichia coli with flux balance analysis incorporating differential proteomic efficiencies of energy pathways. BMC Syst. Biol. 2019, 13, 3. [Google Scholar] [CrossRef] [PubMed]
  33. Chen, Y.; Nielsen, J. Energy metabolism controls phenotypes by protein efficiency and allocation. Proc. Natl. Acad. Sci. USA 2019, 116, 17592–17597. [Google Scholar] [CrossRef] [Green Version]
  34. Zeng, H.; Yang, A. Quantification of proteomic and metabolic burdens predicts growth retardation and overflow metabolism in recombinant Escherichia coli. Biotechnol. Bioeng. 2019, 116, 1484–1495. [Google Scholar] [CrossRef]
  35. Chen, Y.; van Pelt-KleinJan, E.; van Olst, B.; Douwenga, S.; Boeren, S.; Bachmann, H.; Molenaar, D.; Nielsen, J.; Teusink, B. Proteome constraints reveal targets for improving microbial fitness in nutrient-rich environments. Mol. Syst. Biol. 2021, 17, e10093. [Google Scholar] [CrossRef]
  36. Liu, J.K.; Lloyd, C.; Al-Bassam, M.M.; Ebrahim, A.; Kim, J.N.; Olson, C.; Aksenov, A.; Dorrestein, P.; Zengler, K. Predicting proteome allocation, overflow metabolism, and metal requirements in a model acetogen. PLoS Comput. Biol. 2019, 15, e1006848. [Google Scholar] [CrossRef] [PubMed]
  37. Lastiri-Pancardo, G.; Mercado-Hernández, J.S.; Kim, J.; Jiménez, J.I.; Utrilla, J. A quantitative method for proteome reallocation using minimal regulatory interventions. Nat. Chem. Biol. 2020, 16, 1026–1033. [Google Scholar] [CrossRef]
  38. de la Cruz, M.; Ramírez, E.A.; Sigala, J.C.; Utrilla, J.; Lara, A.R. Plasmid DNA Production in Proteome-Reduced. Microorganisms 2020, 8, 1444. [Google Scholar] [CrossRef]
  39. Brown, G.C. Total cell protein concentration as an evolutionary constraint on the metabolic control distribution in cells. J. Theor. Biol. 1991, 153, 195–203. [Google Scholar] [CrossRef]
  40. Vazquez, A.; Oltvai, Z.N. Macromolecular crowding explains overflow metabolism in cells. Sci. Rep. 2016, 6, 31007. [Google Scholar] [CrossRef] [Green Version]
  41. Beg, Q.K.; Vazquez, A.; Ernst, J.; de Menezes, M.A.; Bar-Joseph, Z.; Barabási, A.L.; Oltvai, Z.N. Intracellular crowding defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity. Proc. Natl. Acad. Sci. USA 2007, 104, 12663–12668. [Google Scholar] [CrossRef] [Green Version]
  42. Vazquez, A.; Beg, Q.K.; Demenezes, M.A.; Ernst, J.; Bar-Joseph, Z.; Barabási, A.L.; Boros, L.G.; Oltvai, Z.N. Impact of the solvent capacity constraint on E. coli metabolism. BMC Syst. Biol. 2008, 2, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Vazquez, A.; Liu, J.; Zhou, Y.; Oltvai, Z.N. Catabolic efficiency of aerobic glycolysis: The Warburg effect revisited. BMC Syst. Biol. 2010, 4, 58. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. van Hoek, M.J.; Merks, R.M. Redox balance is key to explaining full vs. partial switching to low-yield metabolism. BMC Syst. Biol. 2012, 6, 22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Zhuang, K.; Vemuri, G.N.; Mahadevan, R. Economics of membrane occupancy and respiro-fermentation. Mol. Syst. Biol. 2011, 7, 500. [Google Scholar] [CrossRef] [PubMed]
  46. Szenk, M.; Dill, K.A.; de Graff, A.M.R. Why Do Fast-Growing Bacteria Enter Overflow Metabolism? Testing the Membrane Real Estate Hypothesis. Cell Syst. 2017, 5, 95–104. [Google Scholar] [CrossRef]
  47. Stark, B.C.; Pagilla, K.R.; Dikshit, K.L. Recent applications of Vitreoscilla hemoglobin technology in bioproduct synthesis and bioremediation. Appl. Microbiol. Biotechnol. 2015, 99, 1627–1636. [Google Scholar] [CrossRef]
  48. Efiok, B.J.; Webster, D.A. A cytochrome that can pump sodium ion. Biochem. Biophys. Res. Commun. 1990, 173, 370–375. [Google Scholar] [CrossRef]
  49. Stark, B.C.; Dikshit, K.L.; Pagilla, K.R. The Biochemistry of Vitreoscilla hemoglobin. Comput. Struct. Biotechnol. J. 2012, 3, e201210002. [Google Scholar] [CrossRef] [Green Version]
  50. Stark, B.C.; Dikshit, K.L.; Pagilla, K.R. Recent advances in understanding the structure, function, and biotechnological usefulness of the hemoglobin from the bacterium Vitreoscilla. Biotechnol. Lett. 2011, 33, 1705–1714. [Google Scholar] [CrossRef]
  51. Yu, F.; Zhao, X.; Wang, Z.; Liu, L.; Yi, L.; Zhou, J.; Li, J.; Chen, J.; Du, G. Recent Advances in the Physicochemical Properties and Biotechnological Application of. Microorganisms 2021, 9, 1445. [Google Scholar] [CrossRef]
  52. Webster, D.A.; Dikshit, K.L.; Pagilla, K.R.; Stark, B.C. The Discovery of Vitreoscilla Hemoglobin and Early Studies on Its Biochemical Functions, the Control of Its Expression, and Its Use in Practical Applications. Microorganisms 2021, 9, 1637. [Google Scholar] [CrossRef] [PubMed]
  53. Dikshit, R.P.; Dikshit, K.L.; Liu, Y.X.; Webster, D.A. The bacterial hemoglobin from Vitreoscilla can support the aerobic growth of Escherichia coli lacking terminal oxidases. Arch. Biochem. Biophys. 1992, 293, 241–245. [Google Scholar] [CrossRef]
  54. Dikshit, K.L.; Webster, D.A. Cloning, characterization and expression of the bacterial globin gene from Vitreoscilla in Escherichia coli. Gene 1988, 70, 377–386. [Google Scholar] [CrossRef]
  55. Kallio, P.T.; Kim, D.J.; Tsai, P.S.; Bailey, J.E. Intracellular expression of Vitreoscilla hemoglobin alters Escherichia coli energy metabolism under oxygen-limited conditions. Eur. J. Biochem. 1994, 219, 201–208. [Google Scholar] [CrossRef] [PubMed]
  56. Jaén, K.E.; Velazquez, D.; Delvigne, F.; Sigala, J.C.; Lara, A.R. Engineering, E. coli for improved microaerobic pDNA production. Bioprocess Biosyst. Eng. 2019, 42, 1457–1466. [Google Scholar] [CrossRef] [PubMed]
  57. Khosla, C.; Bailey, J.E. Evidence for partial export of Vitreoscilla hemoglobin into the periplasmic space in Escherichia coli. Implications for protein function. J. Mol. Biol. 1989, 210, 79–89. [Google Scholar] [CrossRef]
  58. Ramandeep; Hwang, K.W.; Raje, M.; Kim, K.J.; Stark, B.C.; Dikshit, K.L.; Webster, D.A. Vitreoscilla hemoglobin. Intracellular localization and binding to membranes. J. Biol. Chem. 2001, 276, 24781–24789. [Google Scholar] [CrossRef] [Green Version]
  59. Juárez, M.; González-De la Rosa, C.H.; Sigala, J.C.; Lara, A.R. Effect of Vitreoscilla hemoglobin on recombinant protein expression and energy metabolism of CHO cells. Rev. Mex. Ing. Quím. 2021, 20, 281–288. [Google Scholar] [CrossRef]
  60. Ouyang, P.; Wang, H.; Hajnal, I.; Wu, Q.; Guo, Y.; Chen, G.Q. Increasing oxygen availability for improving poly(3-hydroxybutyrate) production by Halomonas. Metab. Eng. 2018, 45, 20–31. [Google Scholar] [CrossRef]
  61. Suen, Y.L.; Tang, H.; Huang, J.; Chen, F. Enhanced production of fatty acids and astaxanthin in Aurantiochytrium sp. by the expression of Vitreoscilla hemoglobin. J. Agric. Food Chem. 2014, 62, 12392–12398. [Google Scholar] [CrossRef]
  62. Juárez, M.; González-De la Rosa, C.H.; Memún, E.; Sigala, J.C.; Lara, A.R. Aerobic expression of Vitreoscilla hemoglobin improves the growth performance of CHO-K1 cells. Biotechnol. J. 2017, 12. [Google Scholar] [CrossRef] [PubMed]
  63. Liu, Q.; Zhang, J.; Wei, X.X.; Ouyang, S.P.; Wu, Q.; Chen, G.Q. Microbial production of L -glutamate and L -glutamine by recombinant Corynebacterium glutamicum harboring Vitreoscilla hemoglobin gene vgb. Appl. Microbiol. Biotechnol. 2008, 77, 1297–1304. [Google Scholar] [CrossRef] [PubMed]
  64. Wu, W.B.; Guo, X.L.; Zhang, M.L.; Huang, Q.G.; Qi, F.; Huang, J.Z. Enhancement of l-phenylalanine production in Escherichia coli by heterologous expression of Vitreoscilla hemoglobin. Biotechnol. Appl. Biochem. 2018, 65, 476–483. [Google Scholar] [CrossRef] [PubMed]
  65. Pablos, T.E.; Sigala, J.C.; Le Borgne, S.; Lara, A.R. Aerobic expression of Vitreoscilla hemoglobin efficiently reduces overflow metabolism in Escherichia coli. Biotechnol. J. 2014, 9, 791–799. [Google Scholar] [CrossRef]
  66. Lara, A.R.; Galindo, J.; Jaén, K.E.; Juárez, M.; Sigala, J.C. Physiological Response of. J. Microbiol. Biotechnol. 2020, 30, 1592–1596. [Google Scholar] [CrossRef]
  67. Liu, D.; Ke, X.; Hu, Z.C.; Zheng, Y.G. Improvement of pyrroloquinoline quinone-dependent d-sorbitol dehydrogenase activity from Gluconobacter oxydans via expression of Vitreoscilla hemoglobin and regulation of dissolved oxygen tension for the biosynthesis of 6-(N-hydroxyethyl)-amino-6-deoxy-α-l-sorbofuranose. J. Biosci. Bioeng. 2021, 131, 518–524. [Google Scholar] [CrossRef]
  68. Zhang, H.; Feng, Y.; Cui, Q.; Song, X. Expression of Vitreoscilla hemoglobin enhances production of arachidonic acid and lipids in Mortierella alpina. BMC Biotechnol. 2017, 17, 68. [Google Scholar] [CrossRef]
  69. Suthar, D.H.; Chattoo, B.B. Expression of Vitreoscilla hemoglobin enhances growth and levels of alpha-amylase in Schwanniomyces occidentalis. Appl. Microbiol. Biotechnol. 2006, 72, 94–102. [Google Scholar] [CrossRef]
  70. Wu, J.M.; Hsu, T.A.; Lee, C.K. Expression of the gene coding for bacterial hemoglobin improves beta-galactosidase production in a recombinant Pichia pastoris. Biotechnol. Lett. 2003, 25, 1457–1462. [Google Scholar] [CrossRef]
  71. Wang, X.; Sun, Y.; Shen, X.; Ke, F.; Zhao, H.; Liu, Y.; Xu, L.; Yan, Y. Intracellular expression of Vitreoscilla hemoglobin improves production of Yarrowia lipolytica lipase LIP2 in a recombinant Pichia pastoris. Enzyme. Microb. Technol. 2012, 50, 22–28. [Google Scholar] [CrossRef]
  72. Bhave, S.L.; Chattoo, B.B. Expression of vitreoscilla hemoglobin improves growth and levels of extracellular enzyme in Yarrowia lipolytica. Biotechnol. Bioeng. 2003, 84, 658–666. [Google Scholar] [CrossRef]
  73. Huberts, D.H.; Niebel, B.; Heinemann, M. A flux-sensing mechanism could regulate the switch between respiration and fermentation. FEMS Yeast Res. 2012, 12, 118–128. [Google Scholar] [CrossRef] [Green Version]
  74. Pinu, F.R.; Granucci, N.; Daniell, J.; Han, T.L.; Carneiro, S.; Rocha, I.; Nielsen, J.; Villas-Boas, S.G. Metabolite secretion in microorganisms: The theory of metabolic overflow put to the test. Metabolomics 2018, 14, 43. [Google Scholar] [CrossRef] [Green Version]
  75. Liu, J.; Li, H.; Zhao, G.; Caiyin, Q.; Qiao, J. Redox cofactor engineering in industrial microorganisms: Strategies, recent applications and future directions. J. Ind. Microbiol. Biotechnol. 2018, 45, 313–327. [Google Scholar] [CrossRef]
  76. Niebel, B.; Leupold, S.; Heinemann, M. An upper limit on Gibbs energy dissipation governs cellular metabolism. Nat. Metab. 2019, 1, 125–132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Millard, P.; Enjalbert, B.; Uttenweiler-Joseph, S.; Portais, J.C.; Létisse, F. Control and regulation of acetate overflow in Escherichia coli. Elife 2021, 10, e63661. [Google Scholar] [CrossRef] [PubMed]
  78. Mori, M.; Marinari, E.; De Martino, A. A yield-cost tradeoff governs Escherichia coli’s decision between fermentation and respiration in carbon-limited growth. NPJ Syst. Biol. Appl. 2019, 5, 16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  79. de Groot, D.H.; Lischke, J.; Muolo, R.; Planqué, R.; Bruggeman, F.J.; Teusink, B. The common message of constraint-based optimization approaches: Overflow metabolism is caused by two growth-limiting constraints. Cell Mol. Life Sci. 2020, 77, 441–453. [Google Scholar] [CrossRef] [Green Version]
  80. Shimizu, K.; Matsuoka, Y. Redox rebalance against genetic perturbations and modulation of central carbon metabolism by the oxidative stress regulation. Biotechnol. Adv. 2019, 37, 107441. [Google Scholar] [CrossRef]
  81. Cheng, C.; O’Brien, E.J.; McCloskey, D.; Utrilla, J.; Olson, C.; LaCroix, R.A.; Sandberg, T.E.; Feist, A.M.; Palsson, B.O.; King, Z.A. Laboratory evolution reveals a two-dimensional rate-yield tradeoff in microbial metabolism. PLoS Comput. Biol. 2019, 15, e1007066. [Google Scholar] [CrossRef] [Green Version]
  82. Tsai, P.S.; Nägeli, M.; Bailey, J.E. Intracellular expression of Vitreoscilla hemoglobin modifies microaerobic Escherichia coli metabolism through elevated concentration and specific activity of cytochrome o. Biotechnol. Bioeng. 1996, 49, 151–160. [Google Scholar] [CrossRef]
  83. Puustinen, A.; Finel, M.; Haltia, T.; Gennis, R.B.; Wikström, M. Properties of the two terminal oxidases of Escherichia coli. Biochemistry 1991, 30, 3936–3942. [Google Scholar] [CrossRef]
  84. Orth, J.D.; Conrad, T.M.; Na, J.; Lerman, J.A.; Nam, H.; Feist, A.M.; Palsson, B. A comprehensive genome-scale reconstruction of Escherichia coli metabolism--2011. Mol. Syst. Biol. 2011, 7, 535. [Google Scholar] [CrossRef]
  85. Schellenberger, J.; Que, R.; Fleming, R.; Thiele, I.; Orth, J.; Feist, A.; Zielinski, D.; Bordbar, A.; Lewis, N.; Rahmanian, S.; et al. Quantitative prediction of cellular metabolism with constraint-based models: The COBRA Toolbox v2.0. Nat. Protoc. 2011, 6, 1290–1307. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Taymaz-Nikerel, H.; Borujeni, A.E.; Verheijen, P.J.; Heijnen, J.J.; van Gulik, W.M. Genome-derived minimal metabolic models for Escherichia coli MG1655 with estimated in vivo respiratory ATP stoichiometry. Biotechnol. Bioeng. 2010, 107, 369–381. [Google Scholar] [CrossRef] [PubMed]
  87. Kalnenieks, U.; Balodite, E.; Rutkis, R. Metabolic Engineering of Bacterial Respiration: High vs. Low P/O and the Case of. Front. Bioeng. Biotechnol. 2019, 7, 327. [Google Scholar] [CrossRef] [Green Version]
  88. Fischer, E.; Zamboni, N.; Sauer, U. High-throughput metabolic flux analysis based on gas chromatography-mass spectrometry derived 13C constraints. Anal. Biochem. 2004, 325, 308–316. [Google Scholar] [CrossRef]
  89. Carlson, R.; Srienc, F. Fundamental Escherichia coli biochemical pathways for biomass and energy production: Creation of overall flux states. Biotechnol. Bioeng. 2004, 86, 149–162. [Google Scholar] [CrossRef]
Figure 1. Overview of Overflow Metabolism as Originated from a Metabolic Imbalance. (A): NADH regeneration rate can be insufficient for given substrate and oxygen uptake rates (qS and qO2, respectively) to fully oxidize the carbon source to CO2 (qCO2). Therefore, overflow metabolites are produced (qoverflow) to contribute to NADH regeneration. (B): Initially qO2 displays a linear correlation with qS. However, at some point qO2 reaches a maximum (qO2, crit) and qS continues increasing, with the concomitant production of overflow metabolites.
Figure 1. Overview of Overflow Metabolism as Originated from a Metabolic Imbalance. (A): NADH regeneration rate can be insufficient for given substrate and oxygen uptake rates (qS and qO2, respectively) to fully oxidize the carbon source to CO2 (qCO2). Therefore, overflow metabolites are produced (qoverflow) to contribute to NADH regeneration. (B): Initially qO2 displays a linear correlation with qS. However, at some point qO2 reaches a maximum (qO2, crit) and qS continues increasing, with the concomitant production of overflow metabolites.
Microorganisms 10 00043 g001
Figure 2. Distribution of Fluxes with Varying P/O ratio. Biomass production is Maximized, Constraints qS = −11 mmol g−1h−1 [88], qO2 = −8 mmol g−1h−1 for wild type (blue) and −8 × 1.25 mmol g−1h−1 in the presence of VHb (red).
Figure 2. Distribution of Fluxes with Varying P/O ratio. Biomass production is Maximized, Constraints qS = −11 mmol g−1h−1 [88], qO2 = −8 mmol g−1h−1 for wild type (blue) and −8 × 1.25 mmol g−1h−1 in the presence of VHb (red).
Microorganisms 10 00043 g002
Figure 3. Distribution of fluxes with varying P/O ratio. Biomass production is maximized, constraints qS = −11 mmol g−1h−1, qO2 = −15 mmol g−1h−1 [89] for wild type (blue) and −15 × 1.25 mmol g−1h−1 in the presence of VHb (red).
Figure 3. Distribution of fluxes with varying P/O ratio. Biomass production is maximized, constraints qS = −11 mmol g−1h−1, qO2 = −15 mmol g−1h−1 [89] for wild type (blue) and −15 × 1.25 mmol g−1h−1 in the presence of VHb (red).
Microorganisms 10 00043 g003
Table 1. Overflow metabolites in several organisms of industrial relevance.
Table 1. Overflow metabolites in several organisms of industrial relevance.
OrganismMain Overflow Metabolites
Bacillus subtilisAcetoin, acetate [9]
CHO cellsLactate [10]
Clostridium thermocellumLactate, acetate, ethanol [11]
Corynebacterium glutamicumDihydroxyacetone, acetate [12]
Escherichia coliAcetate [13]
Lachance kluyveriEthylacetate [14]
Saccharomyces cerevisiaeEthanol [13]
Penicillium chrysogenumGluconate [15]
Pichia pastorisEthanol, acetate [16]
Table 2. Reported Effects of Vitreoscilla Haemoglobin in Aerobic Cultures.
Table 2. Reported Effects of Vitreoscilla Haemoglobin in Aerobic Cultures.
OrganismReported Effect
Aurantiochytrium sp.44% higher total fatty acid and 9-fold higher astaxanthin contents [61]
CHO cells40–100% increase of tissue plasminogen activator production [62]
μ and biomass yields increase, lactate production per cell decreased by 40% [62]
NAD+/NADH ratio and ATP cell content decreased, NADP+/NADPH ratio increased [59]
Corynebacterium glutamicumSynthesis of biomass increased 10% and L-glutamate production increased 30% [63]
Escherichia coliIncreased qO2, μ and L-phenylalanine production [64]
60% decrease of acetate accumulation when VHb was expressed from a plasmid. Two-fold increase of plasmid DNA yield from biomass in strain W3110 [65]
37% and 50% reduction in acetate production rate in strains W3110 and BL21, respectively, when VHb was expressed from the chromosome. Different impact on the expression of genes from the TCA cycle and cytochromes, depending on the strain (W3110 or BL21) [66]
Gluconobacter oxydans8% increase of volumetric oxidation activity of N-2-hydroxyethyl glucamine [67]
Mortierella alpinaIncreased μ and 1.6-fold higher arachidonic acid production [68]
Schwanniomyces occidentalisμ and alpha-amylase production increased [69]
Pichia pastoris4-fold higher β-galactosidase activity [70]
31.5% higher expression of Y. lipolytica LIP2 lipase [71]
Yarrowia lipolytica23% higher μ, 2.6-fold higher biomass formation, 92% higher RNase production [72]
Table 3. Stoichiometry of dehydrogenases and cytochrome oxidases involved in the E. coli metabolic network [84].
Table 3. Stoichiometry of dehydrogenases and cytochrome oxidases involved in the E. coli metabolic network [84].
Name of the ReactionStoichiometry
NADH dehydrogenaseNADH16pp(2×P/O+1) h[c] + nadh[c] + q8[c] → nad[c] + q8h2[c] +(2×P/O) h[p]
FADH dehydrogenaseFDH4pp(2×P/O+1) h[c] + q8[c] + for[p] → q8h2[c] + co2[p] + (2×P/O) h[p]
Cytochrome oxidase bd-typeCYTBD2pp(P/O) h[c] + 0.5 o2[c] + mql8[c] → h2o[c] + mqn8[c] + (P/O) h[p]
Cytochrome oxidase bd-typeCYTBDpp(P/O) h[c] + 0.5 o2[c] + q8h2[c] → h2o[c] + q8[c] + (P/O) h[p]
Cytochrome oxidase bo-typeCYTBO3_4pp(2×P/O) h[c] + 0.5 o2[c] + q8h2[c] → h2o[c] + q8[c] +(2×P/O) h[p]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Taymaz-Nikerel, H.; Lara, A.R. Vitreoscilla Haemoglobin: A Tool to Reduce Overflow Metabolism. Microorganisms 2022, 10, 43. https://doi.org/10.3390/microorganisms10010043

AMA Style

Taymaz-Nikerel H, Lara AR. Vitreoscilla Haemoglobin: A Tool to Reduce Overflow Metabolism. Microorganisms. 2022; 10(1):43. https://doi.org/10.3390/microorganisms10010043

Chicago/Turabian Style

Taymaz-Nikerel, Hilal, and Alvaro R. Lara. 2022. "Vitreoscilla Haemoglobin: A Tool to Reduce Overflow Metabolism" Microorganisms 10, no. 1: 43. https://doi.org/10.3390/microorganisms10010043

APA Style

Taymaz-Nikerel, H., & Lara, A. R. (2022). Vitreoscilla Haemoglobin: A Tool to Reduce Overflow Metabolism. Microorganisms, 10(1), 43. https://doi.org/10.3390/microorganisms10010043

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop